Your browser doesn't support javascript.
Guidelines: Anaesthesia in the context of COVID-19 pandemic.
Velly, Lionel; Gayat, Etienne; Quintard, Hervé; Weiss, Emmanuel; De Jong, Audrey; Cuvillon, Philippe; Audibert, Gérard; Amour, Julien; Beaussier, Marc; Biais, Matthieu; Bloc, Sébastien; Bonnet, Marie Pierre; Bouzat, Pierre; Brezac, Gilles; Dahyot-Fizelier, Claire; Dahmani, Souhayl; de Queiroz, Mathilde; Di Maria, Sophie; Ecoffey, Claude; Futier, Emmanuel; Geeraerts, Thomas; Jaber, Haithem; Heyer, Laurent; Hoteit, Rim; Joannes-Boyau, Olivier; Kern, Delphine; Langeron, Olivier; Lasocki, Sigismond; Launey, Yoan; le Saché, Frederic; Lukaszewicz, Anne Claire; Maurice-Szamburski, Axel; Mayeur, Nicolas; Michel, Fabrice; Minville, Vincent; Mirek, Sébastien; Montravers, Philippe; Morau, Estelle; Muller, Laurent; Muret, Jane; Nouette-Gaulain, Karine; Orban, Jean Christophe; Orliaguet, Gilles; Perrigault, Pierre François; Plantet, Florence; Pottecher, Julien; Quesnel, Christophe; Reubrecht, Vanessa; Rozec, Bertrand; Tavernier, Benoit.
  • Velly L; Aix-Marseille University, AP-HM, Department of Anaesthesiology and Critical Care Medicine, University Hospital Timone, 13005 Marseille, France; Aix-Marseille University, CNRS, Institut Neuroscience Timone, UMR7289, Marseille, France. Electronic address: lionel.velly@ap-hm.fr.
  • Gayat E; Department of Anaesthesiology and Critical Care, Lariboisière Hospital, DMU Parabol, AP-HP Nord, University of Paris, Paris, France; Inserm UMR-S 942, Cardiovascular Markers in Stress Conditions (MASCOT), University of Paris, Paris, France.
  • Quintard H; Intensive Care Unit, Centre Hospitalier Universitaire de Nice, Pasteur 2 Hospital, Nice, France.
  • Weiss E; Department of Anaesthesiology and Critical Care, Beaujon Hospital, DMU Parabol, AP-HP Nord, Paris, France; Inserm UMR_S1149, Inserm, Université de Paris, Paris, France.
  • De Jong A; Department of Anaesthesia and Intensive Care unit, Regional University Hospital of Montpellier, St-Éloi Hospital, Montpellier, France; PhyMedExp, University of Montpellier, Inserm U1046, CNRS UMR, 9214, Montpellier, France.
  • Cuvillon P; Department of Anaesthesiology, Beaujon Hospital, CHU Carémeau, Nîmes, France.
  • Audibert G; Department of Anaesthesia and Intensive Care, Lorraine University, Nancy University Hospital, 54000 Nancy, France.
  • Amour J; Cardiovascular and Thoracic Surgery Department, Hôpital Privé Jacques-Cartier, 91300 Massy, France.
  • Beaussier M; Département d'Anesthésie, Institut Mutualiste Montsouris, 75014 Paris, France.
  • Biais M; Department of Anaesthesiology and Critical Care, Pellegrin Hospital, CHU de Bordeaux, Bordeaux, France; Inserm UMR-S 1034, Biology of Cardiovascular Diseases, Bordeaux University, Bordeaux, France.
  • Bloc S; CMC Ambroise-Paré, Département d'anesthésie, 92200 Neuilly-sur-Seine, France.
  • Bonnet MP; Department of Anaesthesiology and Critical Care, Armand-Trousseau University Hospital, Assistance publique-Hôpitaux de Paris, Paris, France; Centre for Epidemiology and Statistics Sorbonne Paris Cité (CRESS), Université de Paris, Obstetrical Perinatal and Paediatric Epidemiology Research Team (EPOPé
  • Bouzat P; Department of Anaesthesiology and Intensive Care Medicine, Grenoble University Hospital, 38000 Grenoble, France.
  • Brezac G; Anaesthesiology, Lenval Children's Hospital, 06200 Nice, France.
  • Dahyot-Fizelier C; Anaesthesia and Intensive Care, University Hospital of Poitiers, Poitiers, France; Inserm UMR1070, Pharmacology of Anti-infective Agents, University of Poitiers, Poitiers, France.
  • Dahmani S; Department of Anaesthesia and Intensive Care, Robert-Debré University Hospital, AP-HP, DHU PROTECT, Inserm U1141, Paris, France.
  • de Queiroz M; Department of Paediatric Anaesthesia and Intensive Care, Femme-Mère-Enfant Hospital, Lyon, France.
  • Di Maria S; Department of Anaesthesiology and Critical Care, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France.
  • Ecoffey C; Department of Anaesthesia and Intensive Care, CHU de Rennes, Inserm UMR 991, CIC 1414, Rennes 1 University, Rennes, France.
  • Futier E; Department of Anaesthesiology and Critical Care, Estaing Hospital, CHU de Clermont-Ferrand, Clermont-Ferrand, France; Université Clermont Auvergne, CNRS, Inserm U-1103, Clermont-Ferrand, France.
  • Geeraerts T; Pôle Anesthésie-Réanimation, Inserm, UMR 1214, Toulouse Neuroimaging Centre (ToNIC), université Toulouse 3 - Paul-Sabatier, CHU de Toulouse, 31059 Toulouse, France.
  • Jaber H; Departments of Anaesthesia and Intensive Care, Caen University Hospital, Caen, France.
  • Heyer L; Intensive Care Unit, Department of Anaesthesiology and Intensive Care Medicine, Croix-Rousse Hospital, Lyon, France.
  • Hoteit R; Department of Anaesthesia and Intensive Care unit, Regional University Hospital of Montpellier, St-Éloi Hospital, Montpellier, France.
  • Joannes-Boyau O; Service d'Anesthésie-Réanimation Sud, Centre Médico-Chirurgical Magellan, Centre Hospitalier Universitaire (CHU) de Bordeaux, 33000 Bordeaux, France.
  • Kern D; Departments of Anaesthesia and Intensive Care, Children Hospital, University Hospital of Toulouse, Toulouse, France.
  • Langeron O; Department of Anaesthesiology and Critical Care Medicine, Henri-Mondor University Hospital, University Paris-Est Créteil (UPEC), Assistance publique-Hôpitaux de Paris, Paris, France.
  • Lasocki S; Department of Anaesthesiology and Critical Care Medicine, UBL Université d'Angers, CHU d'Angers, Angers, France.
  • Launey Y; Department of Anaesthesiology and Critical Care Medicine, Centre Hospitalier Universitaire de Rennes, Rennes, France.
  • le Saché F; Department of Anaesthesiology and Intensive Care, DMU DREAM, AP-HP, 6 Sorbonne Université, Paris, France; Clinique Remusat, 75016 Paris, France; Clinique Jouvenet, 75016 Paris, France.
  • Lukaszewicz AC; University of Lyon, EA 7426: Pathophysiology of Injury-Induced Immunosuppression (PI3), Lyon, France; Department of Anaesthesiology and Critical Care, Neurological hospital, Hospices Civils de Lyon, Lyon, France.
  • Maurice-Szamburski A; Department of Anaesthesia, Clinique Monticelli-Velodrome, GDS, 13008 Marseille, France.
  • Mayeur N; Anaesthesiology and intensive care medicine, Clinique Pasteur, 31076 Toulouse, France.
  • Michel F; Department of Paediatric Intensive Care Unit, Assistance publique-Hôpitaux de Marseille, La Timone Hospital, Marseille, France.
  • Minville V; Department of Anaesthesiology and Intensive Care, Toulouse University Hospital, 31432 Toulouse, France; Inserm, U1048, Université Paul-Sabatier, Institute of Metabolic and Cardiovascular Diseases, I2MC, 31432 Toulouse, France.
  • Mirek S; Department of Anaesthesiology and Intensive Care, Dijon University Hospital, 21079 Dijon, France; U-SEEM, Healthcare Simulation Centre of University Hospital of Dijon, 21079 Dijon, France.
  • Montravers P; Department of Anaesthesiology and Critical Care, CHU Bichat-Claude-Bernard, DMU Parabol, AP-HP Nord, University of Paris, Paris, France; Inserm UMR-S 1152, Epidemiology and Physiopathology of Respiratory Diseases, University of Paris, Paris, France.
  • Morau E; Department of Anaesthesiology and Critical Care Medicine, Hôpital Universitaire Arnaud-de-Villeneuve, Montpellier, France.
  • Muller L; Department of Anaesthesiology and Intensive Care, Pain and Emergency Medicine, Nîmes-Caremeau University Hospital, Université Montpellier, place du Professeur-Robert-Debré, 30029 Nîmes cedex 9, France; Physiology Department, EA 2992, Faculty of Medicine, Université Montpellier, Montpellier-Nimes Uni
  • Muret J; Institut Curie PSL Research University, 75005 Paris, France.
  • Nouette-Gaulain K; Department of Anaesthesiology, Intensive Care and Pain, Institut Curie, 75005 Paris, France.
  • Orban JC; Department of Anaesthesiology and Intensive Care Medicine, Nice University Hospital, Nice, France.
  • Orliaguet G; Surgical Paediatric Intensive Care Unit, Universitary Hospital Necker-Enfants-Malades, Paris, France; EA08 Pharmacologie et Évaluation des Thérapeutiques chez l'Enfant et la Femme Enceinte, Paris Descartes University (Paris V), Paris, France.
  • Perrigault PF; Department of Anaesthesia and Critical Care Medicine, Montpellier University, Gui-de-Chauliac Hospital, Montpellier, France.
  • Plantet F; Service d'Anesthésie-Réanimation, Clinique Générale, 4, chemin de la Tour-la-Reine, Annecy, France.
  • Pottecher J; Department of Anaesthesiology and Critical Care, Les Hôpitaux Universitaires de Strasbourg (HUS), Strasbourg, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France.
  • Quesnel C; Inserm UMR-S 1152, Epidemiology and Physiopathology of Respiratory Diseases, University of Paris, Paris, France; Department of Anaesthesiology and Critical Care, Tenon Hospital, DMU DREAM, AP-HP, 6 Sorbonne Université School of Medicine, Paris, France.
  • Reubrecht V; Department of Anaesthesiology and Critical Care, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France.
  • Rozec B; Anesthésie-Réanimation, CHU Nantes, Hôpital Laennec, 1, boulevard Jacques-Monod, 44093 Nantes cedex, France.
  • Tavernier B; Department of Anaesthesiology and Critical Care, CHU de Lille, Pôle d'Anesthésie-Réanimation, 59000 Lille, France.
Anaesth Crit Care Pain Med ; 39(3): 395-415, 2020 06.
Article in English | MEDLINE | ID: covidwho-549176
ABSTRACT

OBJECTIVES:

The world is currently facing an unprecedented healthcare crisis caused by the COVID-19 pandemic. The objective of these guidelines is to produce a framework to facilitate the partial and gradual resumption of intervention activity in the context of the COVID-19 pandemic.

METHODS:

The group has endeavoured to produce a minimum number of recommendations to highlight the strengths to be retained in the 7 predefined areas (1) protection of staff and patients; (2) benefit/risk and patient information; (3) preoperative assessment and decision on intervention; (4) modalities of the preanaesthesia consultation; (5) specificity of anaesthesia and analgesia; (6) dedicated circuits and (7) containment exit type of interventions.

RESULTS:

The SFAR Guideline panel provides 51 statements on anaesthesia management in the context of COVID-19 pandemic. After one round of discussion and various amendments, a strong agreement was reached for 100% of the recommendations and algorithms.

CONCLUSION:

We present suggestions for how the risk of transmission by and to anaesthetists can be minimised and how personal protective equipment policies relate to COVID-19 pandemic context.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Infection Control / Coronavirus Infections / Pandemics / Betacoronavirus / Analgesia / Anesthesia Type of study: Controlled clinical trial / Diagnostic study / Etiology study / Clinical Practice Guide / Prognostic study / Randomized controlled trials / Risk factors Language: English Journal: Anaesth Crit Care Pain Med Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Infection Control / Coronavirus Infections / Pandemics / Betacoronavirus / Analgesia / Anesthesia Type of study: Controlled clinical trial / Diagnostic study / Etiology study / Clinical Practice Guide / Prognostic study / Randomized controlled trials / Risk factors Language: English Journal: Anaesth Crit Care Pain Med Year: 2020 Document Type: Article